Ferriprox

Generic name: Deferiprone

Usage of Ferriprox

Ferriprox binds to iron and removes it from the bloodstream.

Ferriprox is used to treat iron overload caused by blood transfusions in people with thalassemia syndrome or sickle cell disease, which are hereditary red blood cell disorders.

Ferriprox may also be used for purposes not listed in this medication guide.

Ferriprox side effects

Get emergency medical help if you have signs of an allergic reaction to Ferriprox: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Serious and sometimes fatal infections may occur during treatment with Ferriprox. Stop using this medicine and call your doctor right away if you have signs of infection such as:

fever, chills, body aches;

flu symptoms;

skin sores; or

sores in your mouth and throat.

Further doses may be delayed until your infection clears up.

Ferriprox may cause your urine to turn a reddish-brown color. This side effect is usually not harmful. Call your doctor if you also have upper stomach pain, clay-colored stools, or jaundice (yellowing of your skin or the whites of your eyes).

Common Ferriprox side effects may include:

nausea, vomiting, stomach pain;

infections;

joint pain; or

abnormal liver function tests.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Ferriprox

You should not use Ferriprox if you are allergic to Deferiprone.

To make sure Ferriprox is safe for you, tell your doctor if you have ever had:

liver disease; or

a weak immune system.

It is not known whether deferiprone will harm an unborn baby. Both men and women using this medicine should use effective birth control to prevent pregnancy.

If you are a woman, you may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose.

If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.

Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Ferriprox.

You should not breastfeed while using this medicine, and for at least 2 weeks after your last dose.

Ferriprox tablets are used in adults and children 8 years of age and older. Ferriprox Oral Solution is used in adults and children 3 years of age and older.

How to use Ferriprox

Usual Adult and Pediatric Dose for Iron Overload:

Ferriprox Tablets are available in two different 1000 mg formulations, which have different dosing regimens to achieve the same total daily dosage. To prevent medication errors, before prescribing and dispensing, ensure that the tablet formulation is appropriate for the dosing regimen. Each tablet has distinct identifying characteristics.

Ferriprox Tablets (three times a day): - Starting oral dosage: 75 mg/kg/day (actual body weight) in three divided doses - Maximum oral dosage: 99 mg/kg/day (actual body weight) in three divided doses- Round dose to the nearest 500 mg (half-tablet). Uses: Treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes. Treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with sickle cell disease or other anemias. Ferriprox Tablets (twice a day): - Starting oral dosage: 75 mg/kg/day (actual body weight) in two divided doses - Maximum oral dosage: 99 mg/kg/day (actual body weight) in two divided doses - Round the total daily dose to the nearest 500 mg (half-tablet).

Uses: Treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes. Treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with sickle cell disease or other anemias. Ferriprox Oral Solution 80 mg/mL: - Starting oral dosage: 75 mg/kg/day (actual body weight) in three divided doses - Maximum oral dosage: 99 mg/kg/day (actual body weight) in three divided doses - Round dose to the nearest 2.5 mL. Uses: Treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with thalassemia syndromes. Treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with sickle cell disease or other anemias.

Tailor dose to patient response and therapeutic goals (maintenance or reduction of iron burden).

Warnings

Do not use Ferriprox if you are pregnant. It could harm the unborn baby. Both men and women using this medicine should use effective birth control. Women should keep using birth control for at least 6 months after the last dose. Men should keep using birth control for at least 3 months after the last dose.

Stop using Ferriprox and call your doctor right away if you have signs of infection such as: fever, chills, body aches, flu symptoms, skin sores, or sores in your mouth and throat.

What other drugs will affect Ferriprox

If you take any of the following medicines, take your Ferriprox dose 4 hours before or 4 hours after you take the other medicine:

an antiacid that contains aluminum;

a medicine or supplement that contains iron (including ferric citrate, Feosol, Fergon, Ferrocite, Hemocyte, and others; or

vitamin or mineral supplements that contain iron or zinc.

Avoid taking an herbal supplement containing milk thistle.

Other drugs may interact with deferiprone, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.